캘리포니아의 지방간질환 임상 시험
지방간질환 관련 연구 22개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.
캘리포니아의 도시
- San Diego연구 14개
- Los Angeles연구 8개
- Pasadena연구 8개
- Lancaster연구 7개
- Orange연구 5개
- Fresno연구 5개
- Huntington Beach연구 5개
- San Francisco연구 5개
- Rialto연구 5개
- Long Beach연구 4개
- Folsom연구 4개
- Simi Valley연구 3개
- Sacramento연구 3개
- Escondido연구 3개
- Santa Maria연구 3개
공식 연구 텍스트(영어)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Southern California Research Center, Coronado
- California Liver Research Institute, Pasadena
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of California San Diego NAFLD Research Center, La Jolla
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
- 외 2개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Southern California Research Center, Coronado
- Om Research Llc, Lancaster
- Clinnova Research Solutions, Orange
- 외 3개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- San Fernando Valley Health Institute, Canoga Park
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Fresno Clinical Research Center, Fresno
- 외 11개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Coronado
- Akero Clinical Study Site, Escondido
- Akero Clinical Study Site, Folsom
- 외 13개
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Los Angeles
- 외 3개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Om Research, Apple Valley
- ARK Clinical Research - Fountain Valley, Fountain Valley
- UCSD Medical Center, La Jolla
- 외 4개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- 89bio Clinical Study Site, Escondido
- 외 13개
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Camarillo
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- 외 10개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06419374A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Coronado
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Los Angeles
- 외 3개
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Folsom
- 외 6개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Fresno
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Pasadena
- 외 2개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Rialto
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 6. 9. 업데이트됨 · NCT07358546Bicalutamide Therapy in Young Women With NAFLD and PCOS
- University of California San Francisco, San Francisco
피험자 모집 중1상
18세 ~ 42세 · 여성 · 2026. 5. 29. 업데이트됨 · NCT05979389A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Velocity Clinical research, Los Angeles
피험자 모집 중1/2상건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT05648214Androgens and NAFLD Longitudinal Cohort Study
- University of California San Francisco, San Francisco
피험자 모집 중관찰 연구
18세 ~ 42세 · 여성 · 2026. 4. 13. 업데이트됨 · NCT06124261Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- University of California San Diego, La Jolla
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT07518784Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
- University of California San Diego, La Jolla
피험자 모집 중관찰 연구
9세 ~ 18세 · 모든 성별 · 2026. 1. 21. 업데이트됨 · NCT06706856Implementing Food Referrals for Equity and Sustained Health
- Rady Children's Hospital San Diego, San Diego
피험자 모집 중2상건강한 지원자 환영
5세 이상 · 모든 성별 · 2025. 11. 19. 업데이트됨 · NCT06661538Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
피험자 모집 중건강한 지원자 환영
35세 ~ 65세 · 모든 성별 · 2024. 12. 4. 업데이트됨 · NCT05165706ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.